CRSP vs IRM · rev $11.6M vs P/E 136, rev $3.97B
Crispr Therapeutics AG (CRSP) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported IRM revenue for 2026-06-30 was $3.97B. Net income was $255.1M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
CRSP currently screens at market cap $5.42B. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the CRSP and IRM stock pages for the full models.
Not investment advice.